RxDoctor Payments DataLook up a doctor →

Jonathon Knox, DO

Family Medicine · Oklahoma City, OKNPI 1801823505

Payments from drug & device makers

$20,373in general payments, 2019–2025

Across 1,308 payments — averaging $15.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Pfizer$2K
  • AbbVie$2K
  • Amgen$2K
  • GSK$1K
  • plus $10K from 51 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca50$2,168
Novo Nordisk158$1,837
Pfizer147$1,835
AbbVie(2 entities)164$1,640
Amgen(2 entities)72$1,633
GSK87$1,089
Astellas Pharma US Inc55$1,079
Abbott42$1,033
Lilly USA, LLC66$888
Boehringer Ingelheim50$779
Amarin Pharma, Inc.55$677
Bayer39$575
Merck42$475
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$437
Takeda Pharmaceuticals U.S.A., Inc.25$392
Phathom Pharmaceuticals, Inc.20$341
Corium, LLC15$303
Johnson & Johnson18$237
Esperion Therapeutics, Inc.11$237
Eisai Inc.9$225
Sumitomo Pharma America, Inc.12$192
Axsome Therapeutics, Inc.10$191
Antares Pharma, Inc.8$130
Shire North American Group Inc9$129
Sanofi-aventis U.S. LLC9$125
Idorsia Pharmaceuticals US Inc7$122
Biohaven Pharmaceuticals, Inc.8$118
Genentech USA, Inc.8$114
Supernus Pharmaceuticals, Inc.7$106
Ironwood Pharmaceuticals, Inc7$102
Biohaven Pharmaceutical Holding Company Ltd.6$100
Adlon Therapeutics L.p.6$98
Exact Sciences5$89
Novartis6$84
Tris Pharma Inc4$73
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)3$62
Upsher-smith Laboratories LLC3$61
Kowa Pharmaceuticals America, Inc.5$60
Jazz Pharmaceuticals Inc.4$56
Ironshore Pharmaceuticals Inc.3$56
Lundbeck LLC2$44
Aytu Biopharma, Inc.3$37
Radius Health, Inc.1$31
Clarus Therapeutics Inc.3$30
Dynavax Technologies Corporation3$30
Scilex Pharmaceuticals Inc.2$28
IBSA Pharma Inc.2$28
Dexcom, Inc.2$26
Almatica Pharma LLC2$26
Sunovion Pharmaceuticals Inc.2$24
Xeris Pharmaceuticals, Inc.1$24
Medtronic1$23
Sanofi Pasteur Inc.1$22
Ardelyx, Inc.1$16
Halozyme Inc1$14
Alnylam Pharmaceuticals Inc.1$11
Nalpropion Pharmaceuticals LLC1$11

How this compares

$20,373 in reported general payments places this provider in the 95th percentile of 1,730 family medicine providers in Oklahoma.

See all family medicine providers in Oklahoma

Medicare billing

Part B allowed, 2024
$66,296
Medicare patients
413
Services billed
2,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Oklahoma City

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →